This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid014D It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid014D.html Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine. The full table of all monthly collections is: at house-of-papers.com PMC searches were done at moremed.org
PMC7368629 1. Higher frequency of hepatic steatosis at CT among COVID-19-positive patients.
PMC7365123 3. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
PMC7384394 24. The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor.
PMC7351662 34. Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study.
{{tp|p=32683613|t=2020. Higher frequency of hepatic steatosis at CT among COVID-19-positive patients.|pdf=|usr=}} {{tp|p=32653960|t=2020. Type 1 diabetes onset triggered by COVID-19.|pdf=|usr=}} {{tp|p=32683039|t=2020. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.|pdf=|usr=}} {{tp|p=32692724|t=2020. Risk of death by age and gender from CoVID-19 in Peru, March-May, 2020.|pdf=|usr=}} {{tp|p=32658868|t=2020. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32651993|t=2020. Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China.|pdf=|usr=}} {{tp|p=32705587|t=2020. COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants.|pdf=|usr=}} {{tp|p=32703286|t=2020. Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4(+) T cell count.|pdf=|usr=}} {{tp|p=32631770|t=2020. COVID-19 associated parotitis: A case report.|pdf=|usr=}} {{tp|p=32703607|t=2020. A case report of possible novel coronavirus 2019 reinfection.|pdf=|usr=}} {{tp|p=32713605|t=2020. Cardiovascular complications in COVID-19.|pdf=|usr=}} {{tp|p=32712235|t=2020. Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: A very rare, life-threatening complication.|pdf=|usr=}} {{tp|p=32652252|t=2020. Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19.|pdf=|usr=}} {{tp|p=32659414|t=2020. Prevalence of Comorbidities Among Individuals With COVID-19: A Rapid Review of current Literature.|pdf=|usr=}} {{tp|p=32668317|t=2020. COVID-19-Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.|pdf=|usr=}} {{tp|p=32653423|t=2020. The Relationship between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China.|pdf=|usr=}} {{tp|p=32653420|t=2020. Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.|pdf=|usr=}} {{tp|p=32704530|t=2020. Apical Takotsubo Cardiomyopathy in a COVID-19 Patient Presenting with Stroke: A Case Report and Pathophysiologic Insights.|pdf=|usr=}} {{tp|p=32682192|t=2020. Subjective smell and taste changes during the COVID-19 pandemic: Short term recovery.|pdf=|usr=}} {{tp|p=32657817|t=2020. Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.|pdf=|usr=}} {{tp|p=32668165|t=2020. SARS-CoV-2 (COVID-19) and Cystic Fibrosis.|pdf=|usr=}} {{tp|p=32654909|t=2020. ICU outcomes of COVID-19 critically ill patients: An international comparative study.|pdf=|usr=}} {{tp|p=32660852|t=2020. Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates.|pdf=|usr=}} {{tp|p=32678978|t=2020. The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor.|pdf=|usr=}} {{tp|p=32701540|t=2020. Administering CPR to PPE-Protected Healthcare Worker during COVID-19.|pdf=|usr=}} {{tp|p=32717301|t=2020. Smell loss is a prognostic factor for lower severity of COVID-19.|pdf=|usr=}} {{tp|p=32711028|t=2020. COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids.|pdf=|usr=}} {{tp|p=32693208|t=2020. Atopy is predictive of a decreased need for hospitalization for COVID-19.|pdf=|usr=}} {{tp|p=32711053|t=2020. Risk for COVID-19 infection and death among Latinos in the United States: Examining heterogeneity in transmission dynamics.|pdf=|usr=}} {{tp|p=32683456|t=2020. COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Wurzburg and Wuhan.|pdf=|usr=}} {{tp|p=32683455|t=2020. Thrombocytopenia in COVID-19: pathophysiology matters.|pdf=|usr=}} {{tp|p=32671455|t=2020. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.|pdf=|usr=}} {{tp|p=32705368|t=2020. SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications?|pdf=|usr=}} {{tp|p=32690991|t=2020. Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study.|pdf=|usr=}} {{tp|p=32710929|t=2020. An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China.|pdf=|usr=}} {{tp|p=32692241|t=2020. Case analysis of novel coronavirus pneumonia in the Second Hospital of Wuhan Iron and Steel Company, Qingshan District, Wuhan, China.|pdf=|usr=}} {{tp|p=32692230|t=2020. Clinical characteristics and treatment of critically ill patients with COVID-19 in Hebei.|pdf=|usr=}} {{tp|p=32692208|t=2020. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.|pdf=|usr=}} {{tp|p=32603707|t=2020. SURGICAL RESECTIONS OF SUPERINFECTED PNEUMATOCELES IN A COVID-19 PATIENT.|pdf=|usr=}} {{tp|p=32673648|t=2020. Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from Northern Italy.|pdf=|usr=}} {{tp|p=32653452|t=2020. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.|pdf=|usr=}} {{tp|p=32709533|t=2020. Neumomediastino espontaneo en pacientes con COVID-19: una serie de cuatro casos.|pdf=|usr=}}
45. Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation.
46. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
47. Review of guidelines and recommendations from 17 countries highlights the challenges that clinicians face caring for neonates born to mothers with COVID-19.
49. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records.
54. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey.
60. A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2.
64. A 73-Year-Old Man with a History of Hypertension and Ischemic Heart Disease Who Presented with Pain in the Right Flank as a Symptom of COVID-19 Pneumonia.
67. High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
104. Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia.
{{tp|p=32654408|t=2020. Response: D-dimer triage for COVID-19.|pdf=|usr=}} {{tp|p=32652805|t=2020. Letter to the Editor: D-dimer and presumptive diagnosis of COVID-19.|pdf=|usr=}} {{tp|p=32701920|t=2020. Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation.|pdf=|usr=}} {{tp|p=32678949|t=2020. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.|pdf=|usr=}} {{tp|p=32716579|t=2020. Review of guidelines and recommendations from 17 countries highlights the challenges that clinicians face caring for neonates born to mothers with COVID-19.|pdf=|usr=}} {{tp|p=32688440|t=2020. Alcohol: a probable risk factor of COVID-19 severity.|pdf=|usr=}} {{tp|p=32678866|t=2020. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records.|pdf=|usr=}} {{tp|p=32675581|t=2020. Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA.|pdf=|usr=}} {{tp|p=32689813|t=2020. Progressive renal impairment in an older patient with 2019 coronavirus disease (COVID-19): a case report and literature review.|pdf=|usr=}} {{tp|p=32683890|t=2020. What HIV in the brain can teach us about SARS-CoV-2 neurologic complications?|pdf=|usr=}} {{tp|p=32675341|t=2020. Possible Acute Disseminated Encephalomyelitis Related to Severe Acute Respiratory Syndrome Coronavirus 2 Infection.|pdf=|usr=}} {{tp|p=32716580|t=2020. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey.|pdf=|usr=}} {{tp|p=32716553|t=2020. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.|pdf=|usr=}} {{tp|p=32662525|t=2020. Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.|pdf=|usr=}} {{tp|p=32658359|t=2020. SARS-CoV-2, COVID-19, skin and immunology - what do we know so far?|pdf=|usr=}} {{tp|p=32710733|t=2020. Impact of COVID-19 on Nephrology Patients: A Mechanistic Outlook for Pathogenesis of Acute Kidney Injury.|pdf=|usr=}} {{tp|p=32716009|t=2020. Successful Maternal and Fetal Outcomes in COVID-19 Pregnant Women: An Institutional Approach.|pdf=|usr=}} {{tp|p=32710735|t=2020. A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2.|pdf=|usr=}} {{tp|p=32706769|t=2020. Symptoms of Pleurisy as the Initial Presentation of COVID-19.|pdf=|usr=}} {{tp|p=32703927|t=2020. Spontaneous Subcutaneous Emphysema and Pneumomediastinum in COVID-19 Patients: An Indicator of Poor Prognosis?|pdf=|usr=}} {{tp|p=32701934|t=2020. A 29-Year-Old Male with a Fatal Case of COVID-19 Acute Respiratory Distress Syndrome (CARDS) and Ventilator-Induced Lung Injury (VILI).|pdf=|usr=}} {{tp|p=32699203|t=2020. A 73-Year-Old Man with a History of Hypertension and Ischemic Heart Disease Who Presented with Pain in the Right Flank as a Symptom of COVID-19 Pneumonia.|pdf=|usr=}} {{tp|p=32697769|t=2020. A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.|pdf=|usr=}} {{tp|p=32694498|t=2020. Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report.|pdf=|usr=}} {{tp|p=32692733|t=2020. High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=}} {{tp|p=32687485|t=2020. A 46-Year-Old Woman Who Presented with Diabetic Ketoacidosis and COVID-19 Pneumonia with Multiple Pulmonary Thromboemboli: A Case Report.|pdf=|usr=}} {{tp|p=32666105|t=2020. Noteworthy Electrocardiographic Changes Following Pharmacologic Treatment of COVID-19.|pdf=|usr=}} {{tp|p=32694290|t=2020. Portal Vein Thrombosis in a Patient With COVID-19.|pdf=|usr=}} {{tp|p=32694288|t=2020. Upper Gastrointestinal Bleeding Caused by SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32694292|t=2020. ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.|pdf=|usr=}} {{tp|p=32658337|t=2020. Heparin induced thrombocytopenia antibodies in COVID-19.|pdf=|usr=}} {{tp|p=32652405|t=2020. Paranasal sinuses computed tomography findings in anosmia of COVID-19.|pdf=|usr=}} {{tp|p=32698238|t=2020. COVID-19 and Hydatidiform Mole.|pdf=|usr=}} {{tp|p=32678975|t=2020. SARS-CoV2 and pregnancy: an Invisible enemy?|pdf=|usr=}} {{tp|p=32687390|t=2020. Reply to: Fungal Infection During COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?|pdf=|usr=}} {{tp|p=32687389|t=2020. Fungal Infection During COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?|pdf=|usr=}} {{tp|p=32668167|t=2020. Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Non-directed Bronchoalveolar Lavage.|pdf=|usr=}} {{tp|p=32667207|t=2020. Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging and Hematologic Observations.|pdf=|usr=}} {{tp|p=32713123|t=2020. Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient.|pdf=|usr=}} {{tp|p=32659857|t=2020. COVID-19 in lung transplant patients: a case series.|pdf=|usr=}} {{tp|p=32654422|t=2020. Use of tocilizumab in kidney transplant recipients with COVID-19.|pdf=|usr=}} {{tp|p=32654332|t=2020. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A case-control study.|pdf=|usr=}} {{tp|p=32662399|t=2020. Case Report: Novel Coronavirus-A Potential Cause of Acute Pancreatitis?|pdf=|usr=}} {{tp|p=32662395|t=2020. Bulla Formation and Tension Pneumothorax in a Patient with COVID-19.|pdf=|usr=}} {{tp|p=32662394|t=2020. Case Report: COVID-19-Related Pneumothorax-Case Series Highlighting a Significant Complication.|pdf=|usr=}} {{tp|p=32705978|t=2020. Case Report: Pneumothorax and Pneumomediastinum as Uncommon Complications of COVID-19 Pneumonia-Literature Review.|pdf=|usr=}} {{tp|p=32682454|t=2020. SARS-CoV-2: Should We Be Concerned about the Nervous System?|pdf=|usr=}} {{tp|p=32682452|t=2020. Case Report: COVID-19 with Bilateral Adrenal Hemorrhage.|pdf=|usr=}} {{tp|p=32682453|t=2020. Risk Factors for Hospitalization and Mortality due to COVID-19 in Espirito Santo State, Brazil.|pdf=|usr=}} {{tp|p=32666917|t=2020. Case Report: COVID-19-Associated Bilateral Spontaneous Pneumothorax-A Literature Review.|pdf=|usr=}} {{tp|p=32683945|t=2020. Review of COVID-19 Outcomes in Surgical Patients.|pdf=|usr=}} {{tp|p=32681716|t=2020. Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?|pdf=|usr=}} {{tp|p=32643398|t=2020. Association of Black Race with Outcomes in COVID-19 Disease: A Retrospective Cohort Study.|pdf=|usr=}} {{tp|p=32687078|t=2020. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.|pdf=|usr=}} {{tp|p=32701362|t=2020. Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.|pdf=|usr=}} {{tp|p=32687717|t=2020. Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study.|pdf=|usr=}} {{tp|p=32678685|t=2020. SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution.|pdf=|usr=}} {{tp|p=32716217|t=2020. Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study.|pdf=|usr=}} {{tp|p=32715524|t=2020. Covid-19-associated encephalopathy and cytokine-mediated neuroinflammation.|pdf=|usr=}} {{tp|p=32709680|t=2020. Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia.|pdf=|usr=}} {{tp|p=32709678|t=2020. Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan et al.|pdf=|usr=}} {{tp|p=32669300|t=2020. Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia.|pdf=|usr=}} {{tp|p=32660978|t=2020. COVID-19 in patients with rheumatic diseases: what is the real mortality risk?|pdf=|usr=}} {{tp|p=32660976|t=2020. Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al.|pdf=|usr=}} {{tp|p=32680695|t=2020. Diarrhoea and the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32709685|t=2020. COVID-19 in children with chronic kidney disease: findings from the UK renal registry.|pdf=|usr=}} {{tp|p=32657602|t=2020. The COVID-19 Outbreak in Iran; The First Patient with a Definite Diagnosis.|pdf=|usr=}} {{tp|p=32687400|t=2020. COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease.|pdf=|usr=}} {{tp|p=32657623|t=2020. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses.|pdf=|usr=}} {{tp|p=32662072|t=2020. Gestational diabetes mellitus testing in the COVID-19 pandemic: The problems with simplifying the diagnostic process.|pdf=|usr=}}
PMC7361038 113. Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China.
118. Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.
PMC7364396 120. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
PMC7352096 122. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report.
PMC7341421 142. Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade.
PMC7385789 164. Lessons of the month 3: ST-elevation myocardial infarction and left ventricular thrombus formation: an arterial thrombotic complication of severe COVID-19 infection.
PMC7377683 171. Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement.
{{tp|p=32688107|t=2020. Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China.|pdf=|usr=}} {{tp|p=32696241|t=2020. Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.|pdf=|usr=}} {{tp|p=32707770|t=2020. SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia.|pdf=|usr=}} {{tp|p=32696735|t=2020. Persistent Psychotic Symptoms following Covid-19 Disease.|pdf=|usr=}} {{tp|p=32702124|t=2020. COVID-19 coagulopathy, thrombosis, and bleeding.|pdf=|usr=}} {{tp|p=32663827|t=2020. Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.|pdf=|usr=}} {{tp|p=32697931|t=2020. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.|pdf=|usr=}} {{tp|p=32677918|t=2020. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.|pdf=|usr=}} {{tp|p=32677909|t=2020. A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.|pdf=|usr=}} {{tp|p=32652938|t=2020. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report.|pdf=|usr=}} {{tp|p=32690572|t=2020. Uneventful case of COVID-19 in a kidney transplant recipient.|pdf=|usr=}} {{tp|p=32675133|t=2020. Lingual compression for acute macroglossia in a COVID-19 positive patient.|pdf=|usr=}} {{tp|p=32675129|t=2020. Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery.|pdf=|usr=}} {{tp|p=32665398|t=2020. Liver stiffness by transient elastography accompanies illness severity in COVID-19.|pdf=|usr=}} {{tp|p=32665397|t=2020. Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32682993|t=2020. Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review.|pdf=|usr=}} {{tp|p=32681865|t=2020. Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration?|pdf=|usr=}} {{tp|p=32615073|t=2020. Mild and asymptomatic cases of COVID-19 are potential threat for faecal-oral transmission.|pdf=|usr=}} {{tp|p=32670441|t=2020. Retrospective Analysis of 2019-nCov-Infected Cases in Dongyang, Southeastern China.|pdf=|usr=}} {{tp|p=32685180|t=2020. Multiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-Analysis.|pdf=|usr=}} {{tp|p=32666636|t=2020. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.|pdf=|usr=}} {{tp|p=32619034|t=2020. Clinical characteristics of hematological patients concomitant with COVID-19.|pdf=|usr=}} {{tp|p=32650523|t=2020. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.|pdf=|usr=}} {{tp|p=32670618|t=2020. Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart.|pdf=|usr=}} {{tp|p=32683639|t=2020. Clinical Characteristics and In-Hospital Mortality for COVID-19 Across The Globe.|pdf=|usr=}} {{tp|p=32698837|t=2020. Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.|pdf=|usr=}} {{tp|p=32690029|t=2020. Issues for the management of people with diabetes and COVID-19 in ICU.|pdf=|usr=}} {{tp|p=32671601|t=2020. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.|pdf=|usr=}} {{tp|p=32670643|t=2020. Atypical Presentation of COVID-19 Leading to ARDS.|pdf=|usr=}} {{tp|p=32685221|t=2020. Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade.|pdf=|usr=}} {{tp|p=32714844|t=2020. Obstetric and intensive-care strategies in a high-risk pregnancy with critical respiratory failure due to COVID-19: A case report.|pdf=|usr=}} {{tp|p=32704477|t=2020. Fetal deaths in pregnancies with SARS-CoV-2 infection in Brazil: A case series.|pdf=|usr=}} {{tp|p=32637327|t=2020. Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: Two case reports.|pdf=|usr=}} {{tp|p=32629875|t=2020. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32708755|t=2020. The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.|pdf=|usr=}} {{tp|p=32715376|t=2020. Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia.|pdf=|usr=}} {{tp|p=32690850|t=2020. Mechanisms of Stroke in COVID-19.|pdf=|usr=}} {{tp|p=32634813|t=2020. COVID-19 and Stroke: Casual or Causal Role?|pdf=|usr=}} {{tp|p=32707184|t=2020. Does making a diagnosis of ARDS in COVID-19 patients matter?|pdf=|usr=}} {{tp|p=32707181|t=2020. Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship.|pdf=|usr=}} {{tp|p=32654740|t=2020. Clinical and Imaging Features of COVID-19 in a Neonate.|pdf=|usr=}} {{tp|p=32691024|t=2020. COVID-19 and Myocarditis: What Do We Know So Far?|pdf=|usr=}} {{tp|p=32691023|t=2020. COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.|pdf=|usr=}} {{tp|p=32667052|t=2020. Association between cardiovascular manifestation and COVID-19.|pdf=|usr=}} {{tp|p=32667051|t=2020. Cardiovascular manifestations in severe and critical patients with COVID-19.|pdf=|usr=}} {{tp|p=32712049|t=2020. COVID-19 infection and Thrombosis.|pdf=|usr=}} {{tp|p=32681935|t=2020. SARS-CoV-2 and the cardiovascular system.|pdf=|usr=}} {{tp|p=32659224|t=2020. COVID-19: Review and hematologic impact.|pdf=|usr=}} {{tp|p=32669878|t=2020. Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China.|pdf=|usr=}} {{tp|p=32707411|t=2020. Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis.|pdf=|usr=}} {{tp|p=32675158|t=2020. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.|pdf=|usr=}} {{tp|p=32675154|t=2020. Lessons of the month 3: ST-elevation myocardial infarction and left ventricular thrombus formation: an arterial thrombotic complication of severe COVID-19 infection.|pdf=|usr=}} {{tp|p=32628129|t=2020. COVID-19-associated pneumomediastinum.|pdf=|usr=}} {{tp|p=32628128|t=2020. COVID-19 and diabetes: What have we learned so far?|pdf=|usr=}} {{tp|p=32712242|t=2020. Post-COVID-19 chronic symptoms: a post-infectious entity?|pdf=|usr=}} {{tp|p=32710255|t=2020. Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.|pdf=|usr=}} {{tp|p=32701726|t=2020. Secretion of severe acute respiratory syndrome coronavirus 2 in urine.|pdf=|usr=}} {{tp|p=32703535|t=2020. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.|pdf=|usr=}} {{tp|p=32712124|t=2020. Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement.|pdf=|usr=}} {{tp|p=32712122|t=2020. Hyperglycemia is a strong predictor of poor prognosis in COVID-19.|pdf=|usr=}} {{tp|p=32711003|t=2020. Diabetes and COVID-19: A systematic review on the current evidences.|pdf=|usr=}} {{tp|p=32711001|t=2020. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.|pdf=|usr=}} {{tp|p=32710998|t=2020. Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis.|pdf=|usr=}} {{tp|p=32707211|t=2020. COVID-19 and Diabetes: International Diabetes Federation Perspectives.|pdf=|usr=}}
177. Necrotic acral lesions and lung failure in a fatal case of COVID-19.
180. Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy.
188. Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
206. Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China.
207. Presymptomatic Transmission of SARS-CoV-2 Amongst Residents and Staff at a Skilled Nursing Facility: Results of Real-Time PCR and Serologic Testing.
214. What the physicians should know about mast cells, dendritic cells, urticaria and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?
{{tp|p=32671827|t=2020. Necrotic acral lesions and lung failure in a fatal case of COVID-19.|pdf=|usr=}} {{tp|p=32688395|t=2020. Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience.|pdf=|usr=}} {{tp|p=32678428|t=2020. Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients.|pdf=|usr=}} {{tp|p=32659757|t=2020. Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy.|pdf=|usr=}} {{tp|p=32694187|t=2020. Anosmia and loss of smell in the era of covid-19.|pdf=|usr=}} {{tp|p=32680843|t=2020. Covid-19: Intensive care mortality has fallen by a third since pandemic began, researchers find.|pdf=|usr=}} {{tp|p=32675216|t=2020. Obesity and covid-19: the unseen risks.|pdf=|usr=}} {{tp|p=32669308|t=2020. Covid-19: Doctors in France report case of baby infected in utero.|pdf=|usr=}} {{tp|p=32665220|t=2020. Obesity is a potential risk factor for covid-19 associated morbidity and mortality in urban Bangladesh.|pdf=|usr=}} {{tp|p=32651164|t=2020. Covid-19: Symptoms are common after acute phase of disease, Italian study shows.|pdf=|usr=}} {{tp|p=32651302|t=2020. COVID-19 and metabolic syndrome: could diet be the key?|pdf=|usr=}} {{tp|p=32652551|t=2020. Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.|pdf=|usr=}} {{tp|p=32698249|t=2020. Sex-Related Differences in COVID-19 Lethality.|pdf=|usr=}} {{tp|p=32687638|t=2020. SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic.|pdf=|usr=}} {{tp|p=32665054|t=2020. Neurological manifestations in COVID-19 infection: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32665047|t=2020. The dysfunction is in the details: neurovascular changes in COVID-19.|pdf=|usr=}} {{tp|p=32665526|t=2020. Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=}} {{tp|p=32686899|t=2020. Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.|pdf=|usr=}} {{tp|p=32672402|t=2020. COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient.|pdf=|usr=}} {{tp|p=32667726|t=2020. Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection.|pdf=|usr=}} {{tp|p=32710891|t=2020. Venous Thromboembolism in COVID-19 ICU Patients.|pdf=|usr=}} {{tp|p=32673494|t=2020. COVID-19-Associated Stress (Takotsubo) Cardiomyopathy.|pdf=|usr=}} {{tp|p=32677840|t=2020. Microthrombi and ST-Segment Elevation Myocardial Infarction in COVID-19.|pdf=|usr=}} {{tp|p=32673505|t=2020. COVID-19: Myocardial injury in survivors.|pdf=|usr=}} {{tp|p=32658609|t=2020. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.|pdf=|usr=}} {{tp|p=32692697|t=2020. Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization.|pdf=|usr=}} {{tp|p=32699468|t=2020. COVID-19 and Diabetes.|pdf=|usr=}} {{tp|p=32683745|t=2020. COVID-19 and Diabetes: Insulin Requirements Parallel Illness Severity in Critically Unwell Patients.|pdf=|usr=}} {{tp|p=32717066|t=2020. Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study.|pdf=|usr=}} {{tp|p=32697835|t=2020. Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China.|pdf=|usr=}} {{tp|p=32667967|t=2020. Presymptomatic Transmission of SARS-CoV-2 Amongst Residents and Staff at a Skilled Nursing Facility: Results of Real-Time PCR and Serologic Testing.|pdf=|usr=}} {{tp|p=32663849|t=2020. Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris.|pdf=|usr=}} {{tp|p=32709637|t=2020. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK.|pdf=|usr=}} {{tp|p=32711058|t=2020. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.|pdf=|usr=}} {{tp|p=32691730|t=2020. Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report.|pdf=|usr=}} {{tp|p=32698615|t=2020. COVID-19 Virus in a 6-Day-Old Girl Neonate: A Case Report.|pdf=|usr=}} {{tp|p=32675715|t=2020. Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases.|pdf=|usr=}} {{tp|p=32713127|t=2020. What the physicians should know about mast cells, dendritic cells, urticaria and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?|pdf=|usr=}} {{tp|p=32700814|t=2020. COVID-19 infection in patients with Sezary syndrome: report of two cases.|pdf=|usr=}} {{tp|p=32700813|t=2020. Disseminated Intravascular Coagulation: A Devastating Systemic Disorder of Special Concern with COVID-19.|pdf=|usr=}} {{tp|p=32697027|t=2020. Urticaria in an Infant with SARS-CoV-2 Positivity.|pdf=|usr=}} {{tp|p=32691948|t=2020. Cutaneous Manifestations of Covid 19: A Case Report & a new finding from Egypt.|pdf=|usr=}} {{tp|p=32654404|t=2020. Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: is there a role for Interleukin 17?|pdf=|usr=}} {{tp|p=32669391|t=2020. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.|pdf=|usr=}} {{tp|p=32669390|t=2020. Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19.|pdf=|usr=}} {{tp|p=32683744|t=2020. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.|pdf=|usr=}} {{tp|p=32683333|t=2020. COVID-19-associated coagulopathy.|pdf=|usr=}} {{tp|p=32703727|t=2020. SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor alpha therapy?|pdf=|usr=}}
225. What are considerations for neonates at risk for COVID-19?
PMC7326630 234. Fatal COVID-19 in a Patient with End-Stage Liver Disease Wait-Listed for Liver Transplantation: An Evidence-Based Review of COVID-19 Screening Modalities Prior to Transplant.
PMC7373836 240. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19.
PMC7328443 246. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
PMC7357335 250. Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
PMC7319940 255. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
PMC7345379 256. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).
PMC7340589 257. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review.
PMC7362820 259. Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
PMC7373685 261. Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center.
PMC7354258 265. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19.
PMC7364287 268. Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?
PMC7336120 273. Sex differences in the relationship between digit ratio (2D:4D) and national case fatality rates for COVID-19: A reply to Sahin (2020).
PMC7356124 274. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool.
PMC7377803 281. Diagnostic performance of initial blood urea nitrogen combined with D-Dimer levels for predicting in-hospital mortality in COVID-19 patients.
{{tp|p=32683803|t=2020. What are considerations for neonates at risk for COVID-19?|pdf=|usr=}} {{tp|p=32683810|t=2020. Management of the first newborn delivered by a mother with COVID-19 in South Korea.|pdf=|usr=}} {{tp|p=32685191|t=2020. The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms.|pdf=|usr=}} {{tp|p=32621743|t=2020. ACE inhibitors/ARB use and COVID-19. Time to change practice or keep gathering data?|pdf=|usr=}} {{tp|p=32621738|t=2020. Commentary: Rapid Testing of Healthcare Employees for COVID-19: What Can We Learn from the Seattle Experience?|pdf=|usr=}} {{tp|p=32699615|t=2020. Coronavirus disease 2019 in chronic kidney disease.|pdf=|usr=}} {{tp|p=32699613|t=2020. Kidney disease and electrolytes in COVID-19: more than meets the eye.|pdf=|usr=}} {{tp|p=32695330|t=2020. Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study.|pdf=|usr=}} {{tp|p=32695319|t=2020. Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury.|pdf=|usr=}} {{tp|p=32617159|t=2020. Fatal COVID-19 in a Patient with End-Stage Liver Disease Wait-Listed for Liver Transplantation: An Evidence-Based Review of COVID-19 Screening Modalities Prior to Transplant.|pdf=|usr=}} {{tp|p=32619736|t=2020. Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19.|pdf=|usr=}} {{tp|p=32659385|t=2020. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.|pdf=|usr=}} {{tp|p=32654082|t=2020. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.|pdf=|usr=}} {{tp|p=32690562|t=2020. High mortality is expected in patients who have COVID-19 during the postoperative period.|pdf=|usr=}} {{tp|p=32660940|t=2020. SARS-CoV-2-related chilblains.|pdf=|usr=}} {{tp|p=32698840|t=2020. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19.|pdf=|usr=}} {{tp|p=32677972|t=2020. Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32664990|t=2020. Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32660650|t=2020. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.|pdf=|usr=}} {{tp|p=32660520|t=2020. Neurological manifestations of COVID-19: a systematic review.|pdf=|usr=}} {{tp|p=32653019|t=2020. COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features.|pdf=|usr=}} {{tp|p=32618700|t=2020. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.|pdf=|usr=}} {{tp|p=32618699|t=2020. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.|pdf=|usr=}} {{tp|p=32617244|t=2020. A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin.|pdf=|usr=}} {{tp|p=32676257|t=2020. Immune Thrombocytopenia Purpura Secondary to COVID-19.|pdf=|usr=}} {{tp|p=32670726|t=2020. Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=}} {{tp|p=32656050|t=2020. Acute Effusive Pericarditis: A Late Complication of COVID-19.|pdf=|usr=}} {{tp|p=32670724|t=2020. Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19.|pdf=|usr=}} {{tp|p=32685326|t=2020. Spontaneous Pneumomediastinum Associated With SARS-CoV-2: Infrequent Complication of the Novel Disease.|pdf=|usr=}} {{tp|p=32668401|t=2020. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank.|pdf=|usr=}} {{tp|p=32615377|t=2020. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32668400|t=2020. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).|pdf=|usr=}} {{tp|p=32663789|t=2020. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review.|pdf=|usr=}} {{tp|p=32652495|t=2020. Balanced diet is a major casualty in COVID-19.|pdf=|usr=}} {{tp|p=32683322|t=2020. Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?|pdf=|usr=}} {{tp|p=32668399|t=2020. Hypoglycemia at the time of Covid-19 pandemic.|pdf=|usr=}} {{tp|p=32707213|t=2020. Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center.|pdf=|usr=}} {{tp|p=32687955|t=2020. Diabetes and CoViD-19: experience from the frontline of Internal Medicine wards in Italy.|pdf=|usr=}} {{tp|p=32682810|t=2020. Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity.|pdf=|usr=}} {{tp|p=32663491|t=2020. Comment on "Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus".|pdf=|usr=}} {{tp|p=32663490|t=2020. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19.|pdf=|usr=}} {{tp|p=32683660|t=2020. Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach.|pdf=|usr=}} {{tp|p=32661881|t=2020. Diabetes and Novel Coronavirus Infection: Implications for Treatment.|pdf=|usr=}} {{tp|p=32690985|t=2020. Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?|pdf=|usr=}} {{tp|p=32698424|t=2020. COVID-19 Pneumonia: Three Thoracic Complications in the Same Patient.|pdf=|usr=}} {{tp|p=32690380|t=2020. Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?|pdf=|usr=}} {{tp|p=32705983|t=2020. Transmission of SARS-CoV-2 by Children.|pdf=|usr=}} {{tp|p=32703030|t=2020. MRI of Patients Infected With COVID-19 Revealed Cervical Lymphadenopathy.|pdf=|usr=}} {{tp|p=32659609|t=2020. Sex differences in the relationship between digit ratio (2D:4D) and national case fatality rates for COVID-19: A reply to Sahin (2020).|pdf=|usr=}} {{tp|p=32661796|t=2020. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool.|pdf=|usr=}} {{tp|p=32667418|t=2020. Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.|pdf=|usr=}} {{tp|p=32705411|t=2020. Mechanism of higher risk for COVID-19 in diabetes: a mask to lift.|pdf=|usr=}} {{tp|p=32710359|t=2020. Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32712702|t=2020. COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.|pdf=|usr=}} {{tp|p=32713730|t=2020. COVID-19 in pregnant women: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32711958|t=2020. Dysentery as a rare GI symptom found in COVID-19 patients.|pdf=|usr=}} {{tp|p=32712332|t=2020. Diagnostic performance of initial blood urea nitrogen combined with D-Dimer levels for predicting in-hospital mortality in COVID-19 patients.|pdf=|usr=}} {{tp|p=32710297|t=2020. Respiratory rehabilitation for post-COVID19 patients in spa centers: first steps from theory to practice.|pdf=|usr=}} {{tp|p=32708118|t=2020. Risk Interactions of Coronavirus Infection across Age Groups after the Peak of COVID-19 Epidemic.|pdf=|usr=}} {{tp|p=32709002|t=2020. Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain.|pdf=|usr=}} {{tp|p=32681630|t=2020. The COVID-19 Pandemic: Is It A Wolf Consuming Fertility?|pdf=|usr=}} {{tp|p=32712426|t=2020. ENCEPHALOPATHY IN SEVERE SARS-CoV2 INFECTION: INFLAMMATORY OR INFECTIOUS?|pdf=|usr=}} {{tp|p=32712623|t=2020. The impact of obesity on COVID-19 complications: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32710288|t=2020. Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis.|pdf=|usr=}}
289. The eye: a possible new route of infection in COVID-19.
304. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.
318. Response to letter to the editor: Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.
326. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.
{{tp|p=32713386|t=2020. The eye: a possible new route of infection in COVID-19.|pdf=|usr=}} {{tp|p=32713380|t=2020. Re-detectable positive RT-PCR test results in recovered COVID-19 patients: The potential role of ACE2.|pdf=|usr=}} {{tp|p=32665052|t=2020. Clinical features of fatalities in patients with COVID-19.|pdf=|usr=}} {{tp|p=32699894|t=2020. Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?|pdf=|usr=}} {{tp|p=32691041|t=2020. Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19.|pdf=|usr=}} {{tp|p=32691039|t=2020. ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19.|pdf=|usr=}} {{tp|p=32688380|t=2020. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?|pdf=|usr=}} {{tp|p=32656564|t=2020. COVID-19 and pulmonary embolism: an unwanted alliance.|pdf=|usr=}} {{tp|p=32696045|t=2020. COVID-19 and cardiovascular disease.|pdf=|usr=}} {{tp|p=32676639|t=2020. Multisystem manifestations of COVID-19 in a patient presenting to a heart attack centre.|pdf=|usr=}} {{tp|p=32671381|t=2020. Subclinical coronary artery disease in COVID-19 patients.|pdf=|usr=}} {{tp|p=32678899|t=2020. COVID-19: how things change in a while.|pdf=|usr=}} {{tp|p=32671399|t=2020. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32663257|t=2020. Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series.|pdf=|usr=}} {{tp|p=32698147|t=2020. THYROTOXICOSIS IN PATIENTS WITH COVID-19: THE THYRCOV STUDY.|pdf=|usr=}} {{tp|p=32674071|t=2020. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.|pdf=|usr=}} {{tp|p=32710500|t=2020. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.|pdf=|usr=}} {{tp|p=32663356|t=2020. Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy.|pdf=|usr=}} {{tp|p=32683753|t=2020. Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019.|pdf=|usr=}} {{tp|p=32681611|t=2020. Assessment of neurological manifestations in hospitalized patients with COVID-19.|pdf=|usr=}} {{tp|p=32677329|t=2020. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak.|pdf=|usr=}} {{tp|p=32668062|t=2020. Severe acute respiratory syndrome coronavirus-2 may be an underappreciated pathogen of the central nervous system.|pdf=|usr=}} {{tp|p=32706091|t=2020. Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19.|pdf=|usr=}} {{tp|p=32659126|t=2020. Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19.|pdf=|usr=}} {{tp|p=32673122|t=2020. Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends.|pdf=|usr=}} {{tp|p=32700573|t=2020. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients.|pdf=|usr=}} {{tp|p=32672482|t=2020. Epidemiology, prognosis and clinical manifestation of cardiovascular disease in COVID-19.|pdf=|usr=}} {{tp|p=32686527|t=2020. Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight.|pdf=|usr=}} {{tp|p=32705906|t=2020. MAFLD in COVID-19 patients: an insidious enemy.|pdf=|usr=}} {{tp|p=32713214|t=2020. Response to letter to the editor: Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.|pdf=|usr=}} {{tp|p=32691924|t=2020. Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID-19): an experience in New York.|pdf=|usr=}} {{tp|p=32669289|t=2020. Involvement of liver in COVID-19: systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32666513|t=2020. Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.|pdf=|usr=}} {{tp|p=32675217|t=2020. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.|pdf=|usr=}} {{tp|p=32654313|t=2020. "Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient".|pdf=|usr=}} {{tp|p=32671970|t=2020. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review.|pdf=|usr=}} {{tp|p=32654557|t=2020. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.|pdf=|usr=}} {{tp|p=32654555|t=2020. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.|pdf=|usr=}} {{tp|p=32703323|t=2020. Antimicrobial prescribing practices at a tertiary care center in patients diagnosed with COVID-19 across the continuum of care.|pdf=|usr=}} {{tp|p=32703320|t=2020. Bacterial and Fungal Co-Infections in COVID-19 Patients Hospitalized During the New York City Pandemic Surge.|pdf=|usr=}} {{tp|p=32698922|t=2020. SARS-CoV-2 screening of asymptomatic healthcare workers.|pdf=|usr=}} {{tp|p=32698920|t=2020. Impact of COVID-19 on Pneumonia-Focused Antibiotic Use at an Academic Medical Center.|pdf=|usr=}} {{tp|p=32657186|t=2020. Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic.|pdf=|usr=}} {{tp|p=32683687|t=2020. Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32710552|t=2020. Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19.|pdf=|usr=}} {{tp|p=32686096|t=2020. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.|pdf=|usr=}} {{tp|p=32706925|t=2020. Worldwide maternal deaths due to COVID-19: A brief review.|pdf=|usr=}} {{tp|p=32666701|t=2020. Novel ENT triad of anosmia, ageusia and hearing impairment in COVID-19.|pdf=|usr=}}
PMC7357271 337. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review.
PMC7368625 342. Epidemiological and clinical course of 483 patients with COVID-19 in Wuhan, China: a single-center, retrospective study from the mobile cabin hospital.
354. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol. A cross-sectional study.
PMC7334955 357. Re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748-54.
PMC7334910 358. Reply to Amit Bansal and Anant Kumar's Letter to the Editor re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748-54.
PMC7366559 360. SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients.
PMC7371484 369. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort.
PMC7369577 377. Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia.
PMC7367029 386. Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.
{{tp|p=32685436|t=2020. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review.|pdf=|usr=}} {{tp|p=32683576|t=2020. Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people.|pdf=|usr=}} {{tp|p=32671732|t=2020. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department.|pdf=|usr=}} {{tp|p=32666303|t=2020. Functional and cognitive outcomes after COVID-19 delirium.|pdf=|usr=}} {{tp|p=32662041|t=2020. Clinical and CT features of the COVID-19 infection: comparison among four different age groups.|pdf=|usr=}} {{tp|p=32683596|t=2020. Epidemiological and clinical course of 483 patients with COVID-19 in Wuhan, China: a single-center, retrospective study from the mobile cabin hospital.|pdf=|usr=}} {{tp|p=32661809|t=2020. Vertical transmission of SARS-CoV-2 infection and preterm birth.|pdf=|usr=}} {{tp|p=32651736|t=2020. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.|pdf=|usr=}} {{tp|p=32700058|t=2020. COVID-19 and the brain: impact on nuclear medicine in neurology.|pdf=|usr=}} {{tp|p=32620513|t=2020. Is pregnancy a risk factor of COVID-19?|pdf=|usr=}} {{tp|p=32654789|t=2020. Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection?|pdf=|usr=}} {{tp|p=32653231|t=2020. Reply to correspondence: Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal.|pdf=|usr=}} {{tp|p=32690331|t=2020. Late miscarriage as a presenting manifestation of COVID-19.|pdf=|usr=}} {{tp|p=32682631|t=2020. Ethical considerations relevant to infections in pregnancy: Application to Sars-Covid-19.|pdf=|usr=}} {{tp|p=32703010|t=2020. Conjunctivitis as sole symptom of COVID-19: A case report and review of literature.|pdf=|usr=}} {{tp|p=32679185|t=2020. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?|pdf=|usr=}} {{tp|p=32667152|t=2020. The management of a COVID-free inpatient rehabilitation in a large COVID-19 hospital in Milan during the outbreak.|pdf=|usr=}} {{tp|p=32667150|t=2020. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol. A cross-sectional study.|pdf=|usr=}} {{tp|p=32703771|t=2020. Confronting and mitigating the risk of COVID-19 Associated Pulmonary Aspergillosis (CAPA).|pdf=|usr=}} {{tp|p=32675211|t=2020. COVID-19: Guidance on Palliative care from a European Respiratory Society International Task Force.|pdf=|usr=}} {{tp|p=32660746|t=2020. Re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748-54.|pdf=|usr=}} {{tp|p=32654803|t=2020. Reply to Amit Bansal and Anant Kumar's Letter to the Editor re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748-54.|pdf=|usr=}} {{tp|p=32700669|t=2020. All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England.|pdf=|usr=}} {{tp|p=32695551|t=2020. SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients.|pdf=|usr=}} {{tp|p=32676052|t=2020. Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=}} {{tp|p=32671013|t=2020. A Low Viral Dose in COVID-19 Patient: A Case Report.|pdf=|usr=}} {{tp|p=32687925|t=2020. What is the incidence of COVID-19 in patients with IBD in western countries?|pdf=|usr=}} {{tp|p=32682764|t=2020. Acute on Chronic Liver Failure - Possibly the main culprit of increased mortality in COVID-19 patients with liver disease.|pdf=|usr=}} {{tp|p=32682762|t=2020. COVID-19, ACEI/ARBs and gastrointestinal symptoms: the jury is still out on the association.|pdf=|usr=}} {{tp|p=32682813|t=2020. Microthrombosis Associated with Gastrointestinal Bleeding in COVID-19.|pdf=|usr=}} {{tp|p=32715283|t=2020. Younger ages at risk of Covid-19 mortality in communities of color.|pdf=|usr=}} {{tp|p=32690600|t=2020. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.|pdf=|usr=}} {{tp|p=32660964|t=2020. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort.|pdf=|usr=}} {{tp|p=32676935|t=2020. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32673509|t=2020. Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19.|pdf=|usr=}} {{tp|p=32691004|t=2020. Acute abdomen -like-presentation associated with SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32665890|t=2020. Acute life-threatening cardiac tamponade in a mechanically ventilated patient with COVID-19 pneumonia.|pdf=|usr=}} {{tp|p=32707256|t=2020. Male Balding is a Major Risk Factor for Severe COVID-19.|pdf=|usr=}} {{tp|p=32710927|t=2020. Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19.|pdf=|usr=}} {{tp|p=32711351|t=2020. Acquired infection after intubating patients with COVID-19: A retrospective pilot study.|pdf=|usr=}} {{tp|p=32707517|t=2020. Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia.|pdf=|usr=}} {{tp|p=32708357|t=2020. Clinical Course and Outcomes of Severe Covid-19: A National Scale Study.|pdf=|usr=}} {{tp|p=32708750|t=2020. The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients.|pdf=|usr=}} {{tp|p=32707965|t=2020. COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges.|pdf=|usr=}} {{tp|p=32709482|t=2020. A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy.|pdf=|usr=}} {{tp|p=32718694|t=2020. Heart retransplantation following COVID-19 illness in a heart transplant recipient.|pdf=|usr=}} {{tp|p=32719447|t=2020. Covid-19 and the cardiovascular system: a comprehensive review.|pdf=|usr=}} {{tp|p=32712207|t=2020. Changes in the hospital admission profile of COVID-19 positive patients at a central London trust.|pdf=|usr=}} {{tp|p=32711041|t=2020. Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History.|pdf=|usr=}} {{tp|p=32718894|t=2020. Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.|pdf=|usr=}} {{tp|p=32712106|t=2020. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2.|pdf=|usr=}}
388. High Thrombus Burden in Patients with COVID-19 Presenting with ST-Elevation Myocardial Infarction.
409. Clinical characteristics and outcomes of COVID-19 patients presenting with initial gastrointestinal symptoms in Wuhan, China: a retrospective cohort study.
417. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
440. Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study.
443. Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.
444. Encephalitic syndrome and anosmia in COVID-19: do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
446. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barre syndrome and polyneuritis cranialis in COVID-19 patients: A case series.
447. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients.
{{tp|p=32679155|t=2020. High Thrombus Burden in Patients with COVID-19 Presenting with ST-Elevation Myocardial Infarction.|pdf=|usr=}} {{tp|p=32710477|t=2020. In-Hospital Mortality Rates in Older Patients with COVID-19.|pdf=|usr=}} {{tp|p=32669322|t=2020. AKI in Hospitalized Patients with and without COVID-19: A Comparison Study.|pdf=|usr=}} {{tp|p=32669321|t=2020. Rationing Scarce Resources: The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease.|pdf=|usr=}} {{tp|p=32660968|t=2020. COVID-19, Racism, and Racial Disparities in Kidney Disease: Galvanizing the Kidney Community Response.|pdf=|usr=}} {{tp|p=32675661|t=2020. Musculoskeletal Consequences of COVID-19.|pdf=|usr=}} {{tp|p=32652713|t=2020. Cardiac manifestations in COVID-19 patients-A systematic review.|pdf=|usr=}} {{tp|p=32697344|t=2020. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases.|pdf=|usr=}} {{tp|p=32663259|t=2020. Diabetes, Obesity, and Risk Prediction of Severe COVID-19.|pdf=|usr=}} {{tp|p=32703892|t=2020. Closing the Brief Case: "Not Positive" or "Not Sure"-COVID-19-Negative Results in a Symptomatic Patient.|pdf=|usr=}} {{tp|p=32703891|t=2020. The Brief Case: "Not Positive" or "Not Sure"-COVID-19-Negative Results in a Symptomatic Patient.|pdf=|usr=}} {{tp|p=32694353|t=2020. Management of Immunosuppression During Severe COVID-19 Infection in a Patient With Pulmonary and Cardiac Sarcoidosis.|pdf=|usr=}} {{tp|p=32694351|t=2020. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.|pdf=|usr=}} {{tp|p=32720641|t=2020. Rise in nocturnal respiratory rate during CPAP may be an early sign of COVID-19 in patients with obstructive sleep apnea.|pdf=|usr=}} {{tp|p=32713422|t=2020. OSA as a probable risk factor for severe COVID-19.|pdf=|usr=}} {{tp|p=32652876|t=2020. Indirect skin sign of COVID-19 days: Striae rubrae.|pdf=|usr=}} {{tp|p=32697842|t=2020. Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics.|pdf=|usr=}} {{tp|p=32691645|t=2020. A case of severe psoriatic erythroderma with COVID-19.|pdf=|usr=}} {{tp|p=32677321|t=2020. Diabetes Mellitus Association with Coronavirus Disease 2019 (COVID-19) Severity and Mortality: A Pooled Analysis.|pdf=|usr=}} {{tp|p=32671936|t=2020. Factors Leading to High Morbidity and Mortality of COVID-19 in Patients with Type 2 Diabetes.|pdf=|usr=}} {{tp|p=32713118|t=2020. Liver damage at admission is an independent prognostic factor for COVID-19.|pdf=|usr=}} {{tp|p=32721038|t=2020. Clinical characteristics and outcomes of COVID-19 patients presenting with initial gastrointestinal symptoms in Wuhan, China: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32687551|t=2020. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.|pdf=|usr=}} {{tp|p=32706605|t=2020. Ischemia of the hand and forearm in a 33-year-old COVID-19 patient: a case report.|pdf=|usr=}} {{tp|p=32650881|t=2020. Myocardial edema in COVID-19 on cardiac MRI.|pdf=|usr=}} {{tp|p=32680957|t=2020. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.|pdf=|usr=}} {{tp|p=32663485|t=2020. Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia.|pdf=|usr=}} {{tp|p=32692346|t=2020. Direct Observation of Repeated Infections With Endemic Coronaviruses.|pdf=|usr=}} {{tp|p=32702098|t=2020. Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes.|pdf=|usr=}} {{tp|p=32691641|t=2020. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.|pdf=|usr=}} {{tp|p=32715812|t=2020. Perinatal transmission with SARS-CoV-2 and route of pregnancy termination: a narrative review.|pdf=|usr=}} {{tp|p=32715804|t=2020. ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids.|pdf=|usr=}} {{tp|p=32698646|t=2020. Perinatal management of SARS-CoV-2 infection in a level III University Hospital.|pdf=|usr=}} {{tp|p=32693656|t=2020. Vertical transmission of SARS CoV-2: a systematic review.|pdf=|usr=}} {{tp|p=32689846|t=2020. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19.|pdf=|usr=}} {{tp|p=32674646|t=2020. Maternal mortality and COVID-19.|pdf=|usr=}} {{tp|p=32669014|t=2020. SARS-CoV-2 is not present in the vaginal fluid of pregnant women with COVID-19.|pdf=|usr=}} {{tp|p=32669007|t=2020. Prevalence of SARS-CoV-2 infection in asymtomatic pregnant women and their partners in a tertiary care hospital in Portugal.|pdf=|usr=}} {{tp|p=32669006|t=2020. Proposal for radiologic diagnosis and follow-up of COVID-19 in pregnant women.|pdf=|usr=}} {{tp|p=32669000|t=2020. Do we expect important complications of COVID-19 infection during pregnancy?|pdf=|usr=}} {{tp|p=32664761|t=2020. Considerations on COVID-19 pregnancy: a cases series during outbreak in Bergamo Province, North Italy.|pdf=|usr=}} {{tp|p=32720703|t=2020. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) co-infection in dead patients in Northeastern Iran.|pdf=|usr=}} {{tp|p=32710646|t=2020. Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients.|pdf=|usr=}} {{tp|p=32706426|t=2020. COVID-19 and Coagulation Dysfunction in Adults: A Systematic Review and Meta-analysis.|pdf=|usr=}} {{tp|p=32706411|t=2020. Co-infection of other respiratory pathogens and HIV in COVID-19 patients: is there a pattern?|pdf=|usr=}} {{tp|p=32706409|t=2020. SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort.|pdf=|usr=}} {{tp|p=32706396|t=2020. Coagulation dysfunction is associated with severity of COVID-19: a meta-analysis.|pdf=|usr=}} {{tp|p=32706395|t=2020. Newly diagnosed diabetes mellitus, DKA and COVID-19: causality or coincidence? - A report of 3 cases.|pdf=|usr=}} {{tp|p=32706392|t=2020. Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study.|pdf=|usr=}} {{tp|p=32697372|t=2020. Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man.|pdf=|usr=}} {{tp|p=32692406|t=2020. HIV/SARS-CoV-2 coinfection: A global perspective.|pdf=|usr=}} {{tp|p=32687228|t=2020. Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32687223|t=2020. Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study.|pdf=|usr=}} {{tp|p=32681674|t=2020. Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32681673|t=2020. Are salivary glands the key players in spreading COVID-19 asymptomatic infection?|pdf=|usr=}} {{tp|p=32672844|t=2020. Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.|pdf=|usr=}} {{tp|p=32672843|t=2020. Encephalitic syndrome and anosmia in COVID-19: do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.|pdf=|usr=}} {{tp|p=32672840|t=2020. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019.|pdf=|usr=}} {{tp|p=32662899|t=2020. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barre syndrome and polyneuritis cranialis in COVID-19 patients: A case series.|pdf=|usr=}} {{tp|p=32662893|t=2020. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients.|pdf=|usr=}} {{tp|p=32652541|t=2020. The first reactive arthritis case associated with COVID-19.|pdf=|usr=}}
449. Postnatally-Acquired COVID-19 in Central India.
PMC7347496 452. Adaptation of Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data: Short Communication to International Journal of Antimicrobial Agents.
PMC7331500 476. The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic.
488. A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.
{{tp|p=32651305|t=2020. Postnatally-Acquired COVID-19 in Central India.|pdf=|usr=}} {{tp|p=32683339|t=2020. COVID-19 in a Child With Diabetic Ketoacidosis: An Instigator, a Deviator or a Spectator.|pdf=|usr=}} {{tp|p=32711567|t=2020. Mistakes from the HIV pandemic should inform the COVID-19 response for maternal and newborn care.|pdf=|usr=}} {{tp|p=32653618|t=2020. Adaptation of Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data: Short Communication to International Journal of Antimicrobial Agents.|pdf=|usr=}} {{tp|p=32715080|t=2020. Association between COVID-19 and cardiovascular disease.|pdf=|usr=}} {{tp|p=32685662|t=2020. COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation.|pdf=|usr=}} {{tp|p=32654049|t=2020. Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic.|pdf=|usr=}} {{tp|p=32698320|t=2020. Symptoms in Health Care Workers during the COVID-19 Epidemic. A Cross-Sectional Survey.|pdf=|usr=}} {{tp|p=32677007|t=2020. Immune thrombocytopenia in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32707088|t=2020. Changes in taste and smell as an early marker for COVID-19.|pdf=|usr=}} {{tp|p=32638046|t=2020. Role of frailty in COVID-19 patients.|pdf=|usr=}} {{tp|p=32661615|t=2020. Early bacterial co-infection in ARDS related to COVID-19.|pdf=|usr=}} {{tp|p=32621268|t=2020. COVID-19 and elderly: beyond the respiratory drama.|pdf=|usr=}} {{tp|p=32686059|t=2020. Thrombosis centres and AVKs monitoring in COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32617907|t=2020. A COVID-19 patient with seven consecutive false-negative rRT-PCR results from sputum specimens.|pdf=|usr=}} {{tp|p=32617903|t=2020. Bilateral lower limb weakness: a cerebrovascular consequence of covid-19 or a complication associated with it?|pdf=|usr=}} {{tp|p=32653981|t=2020. COVID-19, coagulopathy and venous thromboembolism: more questions than answers.|pdf=|usr=}} {{tp|p=32651938|t=2020. Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy.|pdf=|usr=}} {{tp|p=32713924|t=2020. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32669517|t=2020. Coronavirus Disease-19 Pneumonia with Facial Nerve Palsy and Olfactory Disturbance.|pdf=|usr=}} {{tp|p=32655032|t=2020. Response to Comment on; Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report.|pdf=|usr=}} {{tp|p=32655031|t=2020. Comment: Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report.|pdf=|usr=}} {{tp|p=32655021|t=2020. Clinical and Radiologic Characteristics of COVID-19 in Patients With CKD.|pdf=|usr=}} {{tp|p=32655019|t=2020. Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review.|pdf=|usr=}} {{tp|p=32692492|t=2020. The Smell in COVID-19 Infection: Diagnostic Opportunities.|pdf=|usr=}} {{tp|p=32674964|t=2020. Medical Vulnerability of Young Adults to Severe COVID-19 Illness-Data From the National Health Interview Survey.|pdf=|usr=}} {{tp|p=32622895|t=2020. New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus.|pdf=|usr=}} {{tp|p=32622891|t=2020. The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic.|pdf=|usr=}} {{tp|p=32622888|t=2020. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries.|pdf=|usr=}} {{tp|p=32682878|t=2020. Covid Toes: Phenomenon or Epiphenomenon?|pdf=|usr=}} {{tp|p=32622141|t=2020. Risk of COVID-19 in Dermatologic Patients on Long-term Immunomodulatory Therapy.|pdf=|usr=}} {{tp|p=32717534|t=2020. Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection.|pdf=|usr=}} {{tp|p=32720233|t=2020. Severe rapidly progressive Guillain-Barre syndrome in the setting of acute COVID-19 disease.|pdf=|usr=}} {{tp|p=32710910|t=2020. Presentation of SARS-CoV-2 Infection As Cholestatic Jaundice in Two Healthy Adolescents.|pdf=|usr=}} {{tp|p=32720698|t=2020. Rehabilitative of COVID-19 patients with acute lower extremity Ischemia and amputation.|pdf=|usr=}} {{tp|p=32721027|t=2020. Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas.|pdf=|usr=}} {{tp|p=32720012|t=2020. Acute abdomen in patients with SARS-CoV-2 infection or co-infection.|pdf=|usr=}} {{tp|p=32712300|t=2020. The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.|pdf=|usr=}} {{tp|p=32718718|t=2020. Sindrome de guillain-barre tras infeccion por COVID-19.|pdf=|usr=}} {{tp|p=32708858|t=2020. A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.|pdf=|usr=}} {{tp|p=32712222|t=2020. Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19.|pdf=|usr=}} {{tp|p=32696637|t=2020. COVID-19: could sex and age be a risk factor?|pdf=|usr=}} {{tp|p=32711296|t=2020. Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod.|pdf=|usr=}} {{tp|p=32711297|t=2020. COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.|pdf=|usr=}} {{tp|p=32709909|t=2020. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.|pdf=|usr=}} {{tp|p=32719902|t=2020. Effortful speech with distortion of prosody following SARS-CoV-2 infection.|pdf=|usr=}}
495. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection.
497. COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network.
500. Clinical characteristics and outcome of SARS-CoV-2 infection in Italian pediatric oncology patients: a study from the Infectious Diseases Working Group of the AIEOP.
509. COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher alpha2 -Macroglobulin (alpha2-M)?
546. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
557. Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy.
{{tp|p=32718920|t=2020. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32661082|t=2020. A case of limbic encephalitis associated with asymptomatic COVID-19 infection.|pdf=|usr=}} {{tp|p=32651243|t=2020. COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network.|pdf=|usr=}} {{tp|p=32709734|t=2020. Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from (18)F-FDG PET imaging and neuronal autoantibodies.|pdf=|usr=}} {{tp|p=32687574|t=2020. Systemic inflammation with cardiac involvement in pediatric patients with evidence of COVID-19 in a community hospital in the Bronx, NY.|pdf=|usr=}} {{tp|p=32652521|t=2020. Clinical characteristics and outcome of SARS-CoV-2 infection in Italian pediatric oncology patients: a study from the Infectious Diseases Working Group of the AIEOP.|pdf=|usr=}} {{tp|p=32652520|t=2020. Guillain-Barre Syndrome Associated with SARS-CoV-2 Detection and a COVID-19 Infection in a Child.|pdf=|usr=}} {{tp|p=32692708|t=2020. Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM-World Association of Perinatal Medicine.|pdf=|usr=}} {{tp|p=32710575|t=2020. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.|pdf=|usr=}} {{tp|p=32692894|t=2020. Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders?|pdf=|usr=}} {{tp|p=32692877|t=2020. Fibrinolysis and COVID-19: a tale of two sites?|pdf=|usr=}} {{tp|p=32692874|t=2020. The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience.|pdf=|usr=}} {{tp|p=32692862|t=2020. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19.|pdf=|usr=}} {{tp|p=32668058|t=2020. Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis.|pdf=|usr=}} {{tp|p=32663364|t=2020. COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher alpha2 -Macroglobulin (alpha2-M)?|pdf=|usr=}} {{tp|p=32657464|t=2020. Are chilblains a skin expression of COVID-19 microangiopathy?|pdf=|usr=}} {{tp|p=32710617|t=2020. Hypoxia and Thrombosis in COVID-19: New Considerations for Air Passengers.|pdf=|usr=}} {{tp|p=32657339|t=2020. COVID-19 and dengue co-infection in a returning traveller.|pdf=|usr=}} {{tp|p=32653906|t=2020. Guillain-Barre Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient.|pdf=|usr=}} {{tp|p=32693711|t=2020. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.|pdf=|usr=}} {{tp|p=32668494|t=2020. Clinical characteristics in patients with SARS-CoV-2/HBV co-infection.|pdf=|usr=}} {{tp|p=32702751|t=2020. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany.|pdf=|usr=}} {{tp|p=32702090|t=2020. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.|pdf=|usr=}} {{tp|p=32667620|t=2020. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?-Reply.|pdf=|usr=}} {{tp|p=32667618|t=2020. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?|pdf=|usr=}} {{tp|p=32667631|t=2020. Enanthem in Patients With COVID-19 and Skin Rash.|pdf=|usr=}} {{tp|p=32667668|t=2020. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.|pdf=|usr=}} {{tp|p=32662818|t=2020. Outcomes of Universal COVID-19 Testing Following Detection of Incident Cases in 11 Long-term Care Facilities.|pdf=|usr=}} {{tp|p=32701130|t=2020. News Flash!-SARS-CoV-2 Isolated From the Middle Ear and Mastoid.|pdf=|usr=}} {{tp|p=32701126|t=2020. SARS-CoV-2 Virus Isolated From the Mastoid and Middle Ear: Implications for COVID-19 Precautions During Ear Surgery.|pdf=|usr=}} {{tp|p=32672804|t=2020. Olfactory Loss of Function as a Possible Symptom of COVID-19.|pdf=|usr=}} {{tp|p=32672801|t=2020. Olfactory Loss of Function as a Possible Symptom of COVID-19-Reply.|pdf=|usr=}} {{tp|p=32672787|t=2020. Olfactory Loss of Function as a Possible Symptom of COVID-19.|pdf=|usr=}} {{tp|p=32672786|t=2020. Olfactory Loss of Function as a Possible Symptom of COVID-19.|pdf=|usr=}} {{tp|p=32687567|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687565|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687563|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687558|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687557|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687556|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant-Reply.|pdf=|usr=}} {{tp|p=32687555|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687550|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32687548|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant.|pdf=|usr=}} {{tp|p=32686164|t=2020. Prospective study in 355 patients with suspected COVID-19 infection. Value of cough, subjective hyposmia, and hypogeusia.|pdf=|usr=}} {{tp|p=32678494|t=2020. Clinical and Radiological Evaluations of COVID-19 Patients with Anosmia: Preliminary Report.|pdf=|usr=}} {{tp|p=32720649|t=2020. A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with COVID-19.|pdf=|usr=}} {{tp|p=32710672|t=2020. Neuralgic amyotrophy following infection with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32696488|t=2020. Reply: 'Spinal nerve pathology in Guillain-Barre syndrome associated with COVID-19 infection'.|pdf=|usr=}} {{tp|p=32696462|t=2020. Spinal nerve pathology in Guillain-Barre syndrome associated with COVID-19 infection.|pdf=|usr=}} {{tp|p=32678460|t=2020. COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience.|pdf=|usr=}} {{tp|p=32668105|t=2020. Covid-19 and Disparities in Nutrition and Obesity.|pdf=|usr=}} {{tp|p=32678882|t=2020. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.|pdf=|usr=}} {{tp|p=32698732|t=2020. Neurological complications of COVID-19: a systematic review.|pdf=|usr=}} {{tp|p=32680950|t=2020. COVID-19-related encephalopathy responsive to high doses glucocorticoids.|pdf=|usr=}} {{tp|p=32680942|t=2020. Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study.|pdf=|usr=}} {{tp|p=32666873|t=2020. Neurovascular and perfusion imaging findings in coronavirus disease 2019: Case report and literature review.|pdf=|usr=}} {{tp|p=32713251|t=2020. COVID-19: A Perspective from Clinical Neurology and Neuroscience.|pdf=|usr=}} {{tp|p=32668037|t=2020. Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices.|pdf=|usr=}} {{tp|p=32686331|t=2020. Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32692903|t=2020. The potential benefit of telmisartan to protect overweight COPD patients from the acquisition of COVID-19.|pdf=|usr=}} {{tp|p=32677752|t=2020. Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with Sars-COV-2.|pdf=|usr=}} {{tp|p=32701763|t=2020. Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion.|pdf=|usr=}} {{tp|p=32701761|t=2020. Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy.|pdf=|usr=}} {{tp|p=32714435|t=2020. COVID-19 in pregnancy: Maintaining clarity with expanding evidence.|pdf=|usr=}} {{tp|p=32674206|t=2020. Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis.|pdf=|usr=}} {{tp|p=32713097|t=2020. Acute Parotitis as a Presentation of COVID-19?|pdf=|usr=}}
PMC7357969 561. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
562. Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy.
576. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain.
PMC7331864 580. Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case Report.
PMC7331863 581. The Impact of COVID-19 Global Pandemic on Morbidity and Mortality of Liver Transplant Recipients Children and Adults: A Systematic Review of Case Series.
591. Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience.
PMC7338208 612. The Correlation of Comorbidities on the Mortality in Patients with COVID-19: an Observational Study Based on the Korean National Health Insurance Big Data.
PMC7351061 629. Cerebral hemorrhage related to vein thrombosis in Covid-19 patients in different Italian hospitals: View point for clinical and imaging implications.
{{tp|p=32674791|t=2020. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?|pdf=|usr=}} {{tp|p=32633594|t=2020. Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy.|pdf=|usr=}} {{tp|p=32677478|t=2020. Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease.|pdf=|usr=}} {{tp|p=32673529|t=2020. The prevalence of cardiovascular comorbidities in COVID-19, SARS and MERS: pooled analysis of published data.|pdf=|usr=}} {{tp|p=32674821|t=2020. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study.|pdf=|usr=}} {{tp|p=32674819|t=2020. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects.|pdf=|usr=}} {{tp|p=32674818|t=2020. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.|pdf=|usr=}} {{tp|p=32674815|t=2020. Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2.|pdf=|usr=}} {{tp|p=32656688|t=2020. COVID-19: review of case reports.|pdf=|usr=}} {{tp|p=32673162|t=2020. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.|pdf=|usr=}} {{tp|p=32697120|t=2020. ADHD as a Risk Factor for Infection With Covid-19.|pdf=|usr=}} {{tp|p=32696836|t=2020. Thrombosis and anticoagulation in COVID-19.|pdf=|usr=}} {{tp|p=32682251|t=2020. Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry.|pdf=|usr=}} {{tp|p=32643874|t=2020. COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.|pdf=|usr=}} {{tp|p=32627330|t=2020. COVID-19 and arterial hypertension: Hypothesis or evidence?|pdf=|usr=}} {{tp|p=32710674|t=2020. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain.|pdf=|usr=}} {{tp|p=32650509|t=2020. Obesity and COVID-19: Oro-Naso-Sensory Perception.|pdf=|usr=}} {{tp|p=32635468|t=2020. Frailty and COVID-19: A Systematic Scoping Review.|pdf=|usr=}} {{tp|p=32679766|t=2020. Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions.|pdf=|usr=}} {{tp|p=32655742|t=2020. Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case Report.|pdf=|usr=}} {{tp|p=32655733|t=2020. The Impact of COVID-19 Global Pandemic on Morbidity and Mortality of Liver Transplant Recipients Children and Adults: A Systematic Review of Case Series.|pdf=|usr=}} {{tp|p=32632667|t=2020. First, do no harm: bilateral radial artery occlusion in a COVID-19 patient.|pdf=|usr=}} {{tp|p=32657079|t=2020. Recurrent Transient Ischemic Attack in a Young Patient with COVID-19.|pdf=|usr=}} {{tp|p=32659709|t=2020. SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England.|pdf=|usr=}} {{tp|p=32657995|t=2020. Smell Disorder Could Warn Head and Neck Surgeons for Diagnosis of COVID-19.|pdf=|usr=}} {{tp|p=32636061|t=2020. Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes.|pdf=|usr=}} {{tp|p=32651031|t=2020. COVID-19 in people living with diabetes: An international consensus.|pdf=|usr=}} {{tp|p=32657484|t=2020. Angiotensin-Converting Enzyme 2 as a Versatile Player in the Management of Coronavirus Disease 2019.|pdf=|usr=}} {{tp|p=32686042|t=2020. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19.|pdf=|usr=}} {{tp|p=32630111|t=2020. Bloodstream Infection by Saccharomyces cerevisiae in Two COVID-19 Patients after Receiving Supplementation of Saccharomyces in the ICU.|pdf=|usr=}} {{tp|p=32664423|t=2020. Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience.|pdf=|usr=}} {{tp|p=32700223|t=2020. Planning for the Post-COVID Syndrome: How Payers Can Mitigate Long-Term Complications of the Pandemic.|pdf=|usr=}} {{tp|p=32671722|t=2020. COVID-19 and Rhabdomyolysis.|pdf=|usr=}} {{tp|p=32619728|t=2020. A focused review on the genital and sexual affection of COVID-19 patients.|pdf=|usr=}} {{tp|p=32673740|t=2020. SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain.|pdf=|usr=}} {{tp|p=32702465|t=2020. SARS-CoV-2 infection among healthcare workers in a hospital in Madrid, Spain.|pdf=|usr=}} {{tp|p=32702463|t=2020. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial study (COVID in Older PEople).|pdf=|usr=}} {{tp|p=32681857|t=2020. COVID-19 Risk Assessments: Shortcomings in the protection of Black, Asian and Minority Ethnic healthcare workers.|pdf=|usr=}} {{tp|p=32669668|t=2020. COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute?|pdf=|usr=}} {{tp|p=32699182|t=2020. Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.|pdf=|usr=}} {{tp|p=32615200|t=2020. Cardiac injury and mortality in COVID-19: A reappraisal.|pdf=|usr=}} {{tp|p=32652166|t=2020. COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.|pdf=|usr=}} {{tp|p=32652163|t=2020. Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae.|pdf=|usr=}} {{tp|p=32628960|t=2020. Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.|pdf=|usr=}} {{tp|p=32631736|t=2020. Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide.|pdf=|usr=}} {{tp|p=32694083|t=2020. Apparent and occult infections of medical staff in a COVID-19 designated hospital.|pdf=|usr=}} {{tp|p=32697865|t=2020. Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China.|pdf=|usr=}} {{tp|p=32657527|t=2020. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.|pdf=|usr=}} {{tp|p=32690444|t=2020. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older.|pdf=|usr=}} {{tp|p=32665858|t=2020. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study.|pdf=|usr=}} {{tp|p=32655013|t=2020. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis.|pdf=|usr=}} {{tp|p=32627443|t=2020. The Correlation of Comorbidities on the Mortality in Patients with COVID-19: an Observational Study Based on the Korean National Health Insurance Big Data.|pdf=|usr=}} {{tp|p=32715672|t=2020. IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.|pdf=|usr=}} {{tp|p=32686373|t=2020. Acute Kidney Injury and Kidney Damage in COVID-19 Patients.|pdf=|usr=}} {{tp|p=32657091|t=2020. A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock.|pdf=|usr=}} {{tp|p=32716901|t=2020. Characteristics and Outcomes of 599 Patients Infected with COVID-19 in Wuhan, China: Based on an Online Reported Sample.|pdf=|usr=}} {{tp|p=32681845|t=2020. Coagulopathy in COVID-19: Focus on vascular thrombotic events.|pdf=|usr=}} {{tp|p=32651137|t=2020. COVID-19 and fungal co-infections: We must keep them in mind.|pdf=|usr=}} {{tp|p=32691342|t=2020. COVID-19 and the kidney: what we think we know so far and what we don't.|pdf=|usr=}} {{tp|p=32688146|t=2020. The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia.|pdf=|usr=}} {{tp|p=32683185|t=2020. Hemorrhagic encephalopathy associated with COVID-19.|pdf=|usr=}} {{tp|p=32696341|t=2020. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?|pdf=|usr=}} {{tp|p=32691236|t=2020. A systematic review of neurological symptoms and complications of COVID-19.|pdf=|usr=}} {{tp|p=32691234|t=2020. Excess neurological death in New York City after the emergence of COVID-19.|pdf=|usr=}} {{tp|p=32676766|t=2020. Not only pulmonary rehabilitation for critically ill patients with COVID-19.|pdf=|usr=}} {{tp|p=32654064|t=2020. Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients.|pdf=|usr=}} {{tp|p=32654063|t=2020. Frontal encephalopathy related to hyperinflammation in COVID-19.|pdf=|usr=}} {{tp|p=32679347|t=2020. Posterior reversible encephalopathy syndrome in patients with COVID-19.|pdf=|usr=}} {{tp|p=32683275|t=2020. Cerebral hemorrhage related to vein thrombosis in Covid-19 patients in different Italian hospitals: View point for clinical and imaging implications.|pdf=|usr=}} {{tp|p=32620231|t=2020. Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19.|pdf=|usr=}} {{tp|p=32666422|t=2020. Ageusia and anosmia, a common sign of COVID-19? A case series from four countries.|pdf=|usr=}} {{tp|p=32673617|t=2020. SARS-CoV-2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child.|pdf=|usr=}} {{tp|p=32632198|t=2020. The clinical course of SARS-CoV-2 positive neonates.|pdf=|usr=}} {{tp|p=32661368|t=2020. Covid-19 and breastfeeding: what's the risk?|pdf=|usr=}} {{tp|p=32685412|t=2020. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission.|pdf=|usr=}} {{tp|p=32653107|t=2020. The interplay between COVID 19 and non-communicable diseases.|pdf=|usr=}} {{tp|p=32661487|t=2020. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia.|pdf=|usr=}} {{tp|p=32653627|t=2020. Atypical skin manifestations during immune checkpoint blockage in COVID19-infected lung cancer patients.|pdf=|usr=}} {{tp|p=32613385|t=2020. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis.|pdf=|usr=}} {{tp|p=32648093|t=2020. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.|pdf=|usr=}} {{tp|p=32648092|t=2020. Aortic thrombus in patients with severe COVID-19: review of three cases.|pdf=|usr=}} {{tp|p=32713810|t=2020. Oral cancer and ACE2 receptor of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32703719|t=2020. Dysgeusia in COVID-19: Possible Mechanisms and Implications.|pdf=|usr=}} {{tp|p=32706299|t=2020. Changing patterns of mortality during the COVID-19 pandemic: Population-based modelling to understand palliative care implications.|pdf=|usr=}} {{tp|p=32705305|t=2020. Fatal cerebral infarct in a child with COVID-19.|pdf=|usr=}} {{tp|p=32709978|t=2020. Crosstalk between COVID-19 and prostate cancer.|pdf=|usr=}} {{tp|p=32707146|t=2020. Outcomes of In-Hospital Cardiac Arrest in Patients with COVID-19 in New York City.|pdf=|usr=}} {{tp|p=32683837|t=2020. Revision exploratoria sobre series de casos de coronavirus (SARS-CoV, MERS-CoV y SARS-CoV-2) y sus resultados obstetricos y neonatales.|pdf=|usr=}} {{tp|p=32718858|t=2020. COVID-19 and cardiovascular comorbidities: An update.|pdf=|usr=}} {{tp|p=32719490|t=2020. A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.|pdf=|usr=}}
{{tp|p=32697005|t=2020. Oral manifestations associated to Covid-19.|pdf=|usr=}} {{tp|p=32662745|t=2020. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.|pdf=|usr=}} {{tp|p=32660334|t=2020. Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis.|pdf=|usr=}} {{tp|p=32699893|t=2020. Corticosteroid Injections and COVID-19 Infection Risk.|pdf=|usr=}} {{tp|p=32683750|t=2020. A male infant with COVID-19 in the context of ARPC1B deficiency.|pdf=|usr=}} {{tp|p=32710684|t=2020. COVID-19 and hereditary spherocytosis: A recipe for hemolysis.|pdf=|usr=}} {{tp|p=32706512|t=2020. Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19.|pdf=|usr=}} {{tp|p=32686287|t=2020. COVID-19 outbreak and pediatric diabetes: perceptions of health care professionals worldwide.|pdf=|usr=}} {{tp|p=32658093|t=2020. AGE-DEPENDENT SENSORY IMPAIRMENT IN COVID-19 INFECTION AND ITS CORRELATION WITH ACE2 EXPRESSION.|pdf=|usr=}} {{tp|p=32658097|t=2020. INTRAUTERINE TRANSMISSION OF SARS-COV-2 INFECTION IN A PRETERM INFANT.|pdf=|usr=}} {{tp|p=32658096|t=2020. Probable Vertical Transmission of SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32658094|t=2020. SARS-COV-2 Maternal-Child Transmission: Can It Occur Before Delivery and How Do We Prove It?|pdf=|usr=}} {{tp|p=32662947|t=2020. COVID-19 in a child with tuberculous airway compression.|pdf=|usr=}} {{tp|p=32663351|t=2020. Awareness And Concerns About Novel Coronavirus Disease 2019 (COVID-19) Among Parents Of Pediatric Liver Transplant Recipients.|pdf=|usr=}} {{tp|p=32680880|t=2020. Early Experience of COVID-19 in a US Children' Hospital.|pdf=|usr=}} {{tp|p=32715498|t=2020. Non-Steroidal Anti-Inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review.|pdf=|usr=}} {{tp|p=32677858|t=2020. COVID-19 Preliminary Case Series: Characteristics of EMS Encounters with Linked Hospital Diagnoses.|pdf=|usr=}} {{tp|p=32699150|t=2020. No clear association emerges between intergenerational relationships and COVID-19 fatality rates from macro-level analyses.|pdf=|usr=}} {{tp|p=32666597|t=2020. Delirium as the first clinical presentation of the coronavirus disease 2019 in an older adult.|pdf=|usr=}} {{tp|p=32720461|t=2020. An overview of the immune mechanisms of viral myocarditis.|pdf=|usr=}} {{tp|p=32687681|t=2020. Neuropathogenic human coronaviruses: A review.|pdf=|usr=}} {{tp|p=32683438|t=2020. Predominance of an altered sense of smell or taste among long-lasting symptoms in patients with mildly symptomatic COVID-19.|pdf=|usr=}}
PMC7338133 673. Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
PMC7365308 678. COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.
PMC7344378 694. Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington.
696. Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey.
PMC7351397 708. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
PMC7347048 718. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
PMC7341026 720. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.
PMC7340215 734. Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects?
PMC7357545 737. SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro.
781. Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions.
{{tp|p=32632558|t=2020. Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?|pdf=|usr=}} {{tp|p=32700024|t=2020. COVID-19-associated vasculitis and vasculopathy.|pdf=|usr=}} {{tp|p=32696172|t=2020. Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32617807|t=2020. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.|pdf=|usr=}} {{tp|p=32617806|t=2020. Successful use of tPA for thrombolysis in COVID related ARDS: a case series.|pdf=|usr=}} {{tp|p=32676883|t=2020. COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.|pdf=|usr=}} {{tp|p=32676882|t=2020. How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.|pdf=|usr=}} {{tp|p=32671609|t=2020. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?|pdf=|usr=}} {{tp|p=32661758|t=2020. Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore.|pdf=|usr=}} {{tp|p=32661757|t=2020. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature.|pdf=|usr=}} {{tp|p=32653986|t=2020. Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19.|pdf=|usr=}} {{tp|p=32691212|t=2020. COVID-19 and Inequity: a Comparative Spatial Analysis of New York City and Chicago Hot Spots.|pdf=|usr=}} {{tp|p=32663524|t=2020. Use of low-molecular-weight heparin in COVID-19 patients.|pdf=|usr=}} {{tp|p=32616176|t=2020. Reply: Acute Myocarditis With Ventricular Noncompaction in a COVID-19 Patient.|pdf=|usr=}} {{tp|p=32616174|t=2020. Acute Myocarditis With Ventricular Noncompaction in a COVID-19 Patient.|pdf=|usr=}} {{tp|p=32616173|t=2020. COVID-19, End-Stage Heart Failure and Outcome: A Word of Caution in Determining the Causal Link.|pdf=|usr=}} {{tp|p=32667669|t=2020. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.|pdf=|usr=}} {{tp|p=32716512|t=2020. Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater Houston, Texas, Area.|pdf=|usr=}} {{tp|p=32706380|t=2020. Medical Leave Associated With COVID-19 Among Emergency Medical System Responders and Firefighters in New York City.|pdf=|usr=}} {{tp|p=32697325|t=2020. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada.|pdf=|usr=}} {{tp|p=32697322|t=2020. Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32639570|t=2020. Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington.|pdf=|usr=}} {{tp|p=32662955|t=2020. Adverse outcomes in SAR-CoV-2 (COVID-19) and SARS virus related pregnancies with probable vertical transmission.|pdf=|usr=}} {{tp|p=32650305|t=2020. Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey.|pdf=|usr=}} {{tp|p=32622040|t=2020. CoVid-19 related dactyitis.|pdf=|usr=}} {{tp|p=32611979|t=2020. Risk factors analysis and nomogram construction of non-survivors in critical patients with COVID-19.|pdf=|usr=}} {{tp|p=32628001|t=2020. A possible benefit from therapeutic anticoagulation in COVID-19: the Dolo hospital experience in Veneto, Italy.|pdf=|usr=}} {{tp|p=32712607|t=2020. Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study.|pdf=|usr=}} {{tp|p=32668515|t=2020. Four cases of coronavirus disease 2019 in the early stage of pandemic of South Korea: a single public hospital experience.|pdf=|usr=}} {{tp|p=32668512|t=2020. Current laboratory diagnosis of coronavirus disease 2019.|pdf=|usr=}} {{tp|p=32653078|t=2020. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.|pdf=|usr=}} {{tp|p=32659210|t=2020. Inflammatory olfactory neuropathy in two patients with COVID-19.|pdf=|usr=}} {{tp|p=32687793|t=2020. COVID-19 in people with diabetes: understanding the reasons for worse outcomes.|pdf=|usr=}} {{tp|p=32621809|t=2020. Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series.|pdf=|usr=}} {{tp|p=32679038|t=2020. Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa.|pdf=|usr=}} {{tp|p=32659214|t=2020. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32659213|t=2020. Coagulation disorder in COVID-19.|pdf=|usr=}} {{tp|p=32645295|t=2020. Assessment of patients who tested positive for COVID-19 after recovery.|pdf=|usr=}} {{tp|p=32622380|t=2020. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study.|pdf=|usr=}} {{tp|p=32687806|t=2020. Potential factors linked to high COVID-19 death rates in British minority ethnic groups.|pdf=|usr=}} {{tp|p=32622375|t=2020. Neurological associations of COVID-19.|pdf=|usr=}} {{tp|p=32619408|t=2020. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study.|pdf=|usr=}} {{tp|p=32649922|t=2020. SARS-CoV-2 infection in conjunctival tissue - Authors' reply.|pdf=|usr=}} {{tp|p=32649921|t=2020. SARS-CoV-2 infection in conjunctival tissue.|pdf=|usr=}} {{tp|p=32652329|t=2020. Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance?|pdf=|usr=}} {{tp|p=32647324|t=2020. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.|pdf=|usr=}} {{tp|p=32641732|t=2020. Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.|pdf=|usr=}} {{tp|p=32641731|t=2020. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.|pdf=|usr=}} {{tp|p=32690880|t=2020. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission.|pdf=|usr=}} {{tp|p=32652139|t=2020. Update on neurological manifestations of COVID-19.|pdf=|usr=}} {{tp|p=32653522|t=2020. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions.|pdf=|usr=}} {{tp|p=32622449|t=2020. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.|pdf=|usr=}} {{tp|p=32690315|t=2020. Trombosis sistemica producida por COVID-19.|pdf=|usr=}} {{tp|p=32615501|t=2020. Beta-thalassemia may protect against COVID 19.|pdf=|usr=}} {{tp|p=32634733|t=2020. Factors involved in low susceptibility to COVID-19: An adaptation of high altitude inhabitants.|pdf=|usr=}} {{tp|p=32634735|t=2020. Have the symptoms of patients with COVID-19 changed over time during hospitalization?|pdf=|usr=}} {{tp|p=32596817|t=2020. Employee presenteeism and occupational acquisition of COVID-19.|pdf=|usr=}} {{tp|p=32629703|t=2020. Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report.|pdf=|usr=}} {{tp|p=32702935|t=2020. An infant with coronavirus disease 2019 in China: A case report.|pdf=|usr=}} {{tp|p=32670532|t=2020. Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation.|pdf=|usr=}} {{tp|p=32670531|t=2020. Severe Autoimmune Hemolytic Anemia in COVID-19 Infection, Safely Treated with Steroids.|pdf=|usr=}} {{tp|p=32670530|t=2020. Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects?|pdf=|usr=}} {{tp|p=32670524|t=2020. Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study.|pdf=|usr=}} {{tp|p=32670522|t=2020. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts.|pdf=|usr=}} {{tp|p=32667461|t=2020. SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro.|pdf=|usr=}} {{tp|p=32673651|t=2020. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany.|pdf=|usr=}} {{tp|p=32673650|t=2020. commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities, Structural Disparities, and Weight Stigma.|pdf=|usr=}} {{tp|p=32677421|t=2020. COVID-19 and obesity.|pdf=|usr=}} {{tp|p=32673298|t=2020. Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020.|pdf=|usr=}} {{tp|p=32673296|t=2020. Symptom Profiles of a Convenience Sample of Patients with COVID-19 - United States, January-April 2020.|pdf=|usr=}} {{tp|p=32697060|t=2020. Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal.|pdf=|usr=}} {{tp|p=32696629|t=2020. Early trends of socio-economic and health indicators influencing case fatality rate of COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32672431|t=2020. Covid-19 and ex-smokers: an underestimated prognostic factor?|pdf=|usr=}} {{tp|p=32672430|t=2020. Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32657563|t=2020. COVID-19 infection outbreak among health care workers: perspective from a low-middle income country.|pdf=|usr=}} {{tp|p=32662742|t=2020. COVID-19 in multiple sclerosis: The Dutch experience.|pdf=|usr=}} {{tp|p=32622338|t=2020. Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab.|pdf=|usr=}} {{tp|p=32698095|t=2020. Multiple sclerosis following SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32650121|t=2020. Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy.|pdf=|usr=}} {{tp|p=32683306|t=2020. COVID-19 in MS and NMOSD: A multicentric online national survey in Chile.|pdf=|usr=}} {{tp|p=32641730|t=2020. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.|pdf=|usr=}} {{tp|p=32665677|t=2020. Transplacental transmission of SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32690910|t=2020. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.|pdf=|usr=}} {{tp|p=32669623|t=2020. Survivorship after COVID-19 ICU stay.|pdf=|usr=}} {{tp|p=32643073|t=2020. Two patients with COVID-19 and a fever-induced Brugada-like electrocardiographic pattern.|pdf=|usr=}} {{tp|p=32643071|t=2020. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19.|pdf=|usr=}} {{tp|p=32661794|t=2020. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.|pdf=|usr=}} {{tp|p=32667047|t=2020. Neurological manifestations of SARS-CoV-2 - a systemic review.|pdf=|usr=}} {{tp|p=32646885|t=2020. COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.|pdf=|usr=}} {{tp|p=32611761|t=2020. Increased CSF levels of IL-1beta, IL-6, and ACE in SARS-CoV-2-associated encephalitis.|pdf=|usr=}} {{tp|p=32643136|t=2020. Is Guillain-Barre syndrome triggered by SARS-CoV-2? Case report and literature review.|pdf=|usr=}} {{tp|p=32643133|t=2020. Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32638135|t=2020. Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?|pdf=|usr=}} {{tp|p=32661885|t=2020. Functional movement disorders in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32656713|t=2020. Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19.|pdf=|usr=}} {{tp|p=32656711|t=2020. A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients.|pdf=|usr=}} {{tp|p=32617741|t=2020. Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study.|pdf=|usr=}} {{tp|p=32653111|t=2020. Electroencephalogram (EEG) in COVID-19: A systematic retrospective study.|pdf=|usr=}} {{tp|p=32659766|t=2020. Obesity and COVID-19: The Two Sides of the Coin.|pdf=|usr=}} {{tp|p=32660813|t=2020. Obesity and mortality of COVID-19. Meta-analysis.|pdf=|usr=}} {{tp|p=32671726|t=2020. Bariatric and Metabolic Surgery Can Prevent People with Obesity from COVID-19 Infection.|pdf=|usr=}} {{tp|p=32704513|t=2020. The Clinical and Radiological Manifestations in Coronavirus Disease 2019 With Negative Nucleic Acid Results.|pdf=|usr=}} {{tp|p=32661498|t=2020. Coronavirus Disease 2019: Associated Multiple Organ Damage.|pdf=|usr=}} {{tp|p=32647981|t=2020. SARS-CoV-2-Infektion und Auge.|pdf=|usr=}} {{tp|p=32651079|t=2020. Letter to the editor in response to COVID-19 presenting as acute pancreatitis.|pdf=|usr=}} {{tp|p=32653530|t=2020. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.|pdf=|usr=}} {{tp|p=32702044|t=2020. Pre-existing traits associated with Covid-19 illness severity.|pdf=|usr=}} {{tp|p=32649661|t=2020. Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis.|pdf=|usr=}} {{tp|p=32678061|t=2020. Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions.|pdf=|usr=}} {{tp|p=32706942|t=2020. Death From COVID-19 in a Patient Receiving Clozapine: Factors Involved and Prevention Strategies to Consider.|pdf=|usr=}} {{tp|p=32654982|t=2020. COVID-19 and diabetes: What does the clinician need to know?|pdf=|usr=}} {{tp|p=32669979|t=2020. Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptoms.|pdf=|usr=}}
PMC7385216 785. Neuroticism as a Marker of Vulnerability to COVID-19 Infection.
PMC7340023 786. Coronavirus disease 2019 mortality: a multivariate ecological analysis in relation to ethnicity, population density, obesity, deprivation and pollution.
PMC7370354 791. Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations.
PMC7370378 792. Lower extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death.
829. Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis.
830. Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort study.
PMC7319924 833. Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation.
PMC7347306 834. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.
{{tp|p=32654438|t=2020. Neuroticism as a Marker of Vulnerability to COVID-19 Infection.|pdf=|usr=}} {{tp|p=32693249|t=2020. Coronavirus disease 2019 mortality: a multivariate ecological analysis in relation to ethnicity, population density, obesity, deprivation and pollution.|pdf=|usr=}} {{tp|p=32655856|t=2020. In the eye of the storm: the right ventricle in COVID-19.|pdf=|usr=}} {{tp|p=32676376|t=2020. Recovery of pneumonia in 27 discharged COVID-19 patients with positive virus detection.|pdf=|usr=}} {{tp|p=32690988|t=2020. COVID-19-associated encephalopathy: Neurological manifestation of COVID-19.|pdf=|usr=}} {{tp|p=32690987|t=2020. Rhabdomyolysis as a manifestation of a severe case of COVID-19: A case report.|pdf=|usr=}} {{tp|p=32677875|t=2020. Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations.|pdf=|usr=}} {{tp|p=32673190|t=2020. Lower extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death.|pdf=|usr=}} {{tp|p=32685906|t=2020. The underrecognized prothrombotic vascular disease of COVID-19.|pdf=|usr=}} {{tp|p=32685905|t=2020. Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome.|pdf=|usr=}} {{tp|p=32685893|t=2020. Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis.|pdf=|usr=}} {{tp|p=32685892|t=2020. Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital.|pdf=|usr=}} {{tp|p=32685886|t=2020. Antiviral anticoagulation.|pdf=|usr=}} {{tp|p=32685883|t=2020. Thrombosis and coagulopathy in COVID-19: An illustrated review.|pdf=|usr=}} {{tp|p=32685882|t=2020. Thrombosis and thromboembolism related to COVID-19: A clarion call for obtaining solid estimates from large-scale multicenter data.|pdf=|usr=}} {{tp|p=32685881|t=2020. Potential role of platelets in COVID-19: Implications for thrombosis.|pdf=|usr=}} {{tp|p=32685880|t=2020. A proposal for staging COVID-19 coagulopathy.|pdf=|usr=}} {{tp|p=32685874|t=2020. Anticoagulation, immortality, and observations of COVID-19.|pdf=|usr=}} {{tp|p=32658837|t=2020. Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.|pdf=|usr=}} {{tp|p=32704471|t=2020. Recurrent positive nucleic acid detection in a recovered COVID-19 patient: A case report and literature review.|pdf=|usr=}} {{tp|p=32665887|t=2020. COVID-19 in a patient with active tuberculosis: A rare case-report.|pdf=|usr=}} {{tp|p=32679369|t=2020. High altitude reduces infection rate of COVID-19 but not case-fatality rate.|pdf=|usr=}} {{tp|p=32631365|t=2020. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score-matching analysis.|pdf=|usr=}} {{tp|p=32685167|t=2020. A case of non-severe COVID-19 complicated by pulmonary embolism.|pdf=|usr=}} {{tp|p=32702395|t=2020. Cardiac tamponade as a cause of cardiac arrest in severe COVID-19 pneumonia.|pdf=|usr=}} {{tp|p=32696883|t=2020. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.|pdf=|usr=}} {{tp|p=32667578|t=2020. Acute Kidney Injury by SARS-CoV-2 virus in patients with COVID-19: an integrative review.|pdf=|usr=}} {{tp|p=32667573|t=2020. Prevention and control measures for neonatal COVID-19 infection: a scoping review.|pdf=|usr=}} {{tp|p=32706216|t=2020. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32680592|t=2020. Comorbilidad y factores pronosticos al ingreso en una cohorte COVID-19 de un hospital general.|pdf=|usr=}} {{tp|p=32643004|t=2020. Endocrine and metabolic aspects of the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32694081|t=2020. Cardiac magnetic resonance characterization of COVID-19 myocarditis.|pdf=|usr=}} {{tp|p=32657550|t=2020. Potenciales biomarcadores predictores de mortalidad en pacientes COVID-19 en el Servicio de Urgencias.|pdf=|usr=}} {{tp|p=32690859|t=2020. Aislamiento de SARS-CoV-2 en tejido reproductor, una posible via de transmision.|pdf=|usr=}} {{tp|p=32667391|t=2020. Severe coronavirus infection in pregnancy: challenging cases report.|pdf=|usr=}} {{tp|p=32609284|t=2020. COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review.|pdf=|usr=}} {{tp|p=32675006|t=2020. Pneumomediastin spontane : une complication rare du COVID-19 ?|pdf=|usr=}} {{tp|p=32682536|t=2020. A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32654078|t=2020. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.|pdf=|usr=}} {{tp|p=32666137|t=2020. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.|pdf=|usr=}} {{tp|p=32681141|t=2020. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.|pdf=|usr=}} {{tp|p=32688169|t=2020. Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19.|pdf=|usr=}} {{tp|p=32668831|t=2020. COVID-19 complicated by Hashimoto's thyroiditis.|pdf=|usr=}} {{tp|p=32700288|t=2020. Possible sequelae in post-SARS-CoV-2 patients: effects on sleep and general health condition.|pdf=|usr=}} {{tp|p=32668007|t=2020. Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis.|pdf=|usr=}} {{tp|p=32662869|t=2020. Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort study.|pdf=|usr=}} {{tp|p=32682444|t=2020. Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol.|pdf=|usr=}} {{tp|p=32636031|t=2020. NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection.|pdf=|usr=}} {{tp|p=32620455|t=2020. Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation.|pdf=|usr=}} {{tp|p=32659462|t=2020. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.|pdf=|usr=}} {{tp|p=32663703|t=2020. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?|pdf=|usr=}} {{tp|p=32688098|t=2020. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.|pdf=|usr=}} {{tp|p=32682004|t=2020. Pulmonary embolism in hospitalised patients with COVID-19.|pdf=|usr=}} {{tp|p=32681359|t=2020. COVID-19 screening in outpatients with risk factors and healthcare workers.|pdf=|usr=}}
